Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$220.09 - $273.15 $340 Million - $423 Million
-1,546,923 Reduced 57.77%
1,130,866 $252 Million
Q4 2023

Feb 13, 2024

BUY
$181.44 - $260.22 $50,621 - $72,601
279 Added 0.01%
2,677,789 $674 Million
Q3 2023

Nov 13, 2023

BUY
$240.69 - $338.77 $18.8 Million - $26.5 Million
78,125 Added 3.01%
2,677,510 $648 Million
Q2 2023

Aug 11, 2023

SELL
$271.54 - $344.06 $116 Million - $147 Million
-426,671 Reduced 14.1%
2,599,385 $894 Million
Q1 2023

May 15, 2023

BUY
$220.43 - $278.69 $155 Million - $196 Million
704,337 Added 30.34%
3,026,056 $843 Million
Q4 2022

Feb 14, 2023

BUY
$151.88 - $228.5 $233 Million - $350 Million
1,533,899 Added 194.7%
2,321,719 $516 Million
Q3 2022

Nov 14, 2022

SELL
$120.36 - $205.88 $171 Million - $293 Million
-1,424,541 Reduced 64.39%
787,820 $149 Million
Q2 2022

Aug 15, 2022

SELL
$116.09 - $227.33 $33.1 Million - $64.8 Million
-285,257 Reduced 11.42%
2,212,361 $276 Million
Q1 2022

May 16, 2022

SELL
$187.51 - $283.98 $51.1 Million - $77.4 Million
-272,402 Reduced 9.83%
2,497,618 $555 Million
Q4 2021

Feb 14, 2022

BUY
$238.08 - $288.0 $147,609 - $178,560
620 Added 0.02%
2,770,020 $796 Million
Q3 2021

Nov 15, 2021

SELL
$250.72 - $291.24 $21.1 Million - $24.5 Million
-84,240 Reduced 2.95%
2,769,400 $738 Million
Q2 2021

Aug 16, 2021

SELL
$235.0 - $310.7 $23.9 Million - $31.6 Million
-101,643 Reduced 3.44%
2,853,640 $782 Million
Q1 2021

May 14, 2021

SELL
$175.6 - $291.43 $51.4 Million - $85.4 Million
-292,909 Reduced 9.02%
2,955,283 $800 Million
Q4 2020

Feb 12, 2021

BUY
$174.98 - $272.83 $293 Million - $457 Million
1,675,367 Added 106.52%
3,248,192 $568 Million
Q3 2020

Nov 13, 2020

BUY
$185.27 - $238.73 $291 Million - $375 Million
1,572,825 New
1,572,825 $306 Million

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.01B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Capital Research Global Investors Portfolio

Follow Capital Research Global Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.